Gooding S, Whistler J
Annu Rev Physiol. 2023; 86:1-25.
PMID: 38029388
PMC: 10987332.
DOI: 10.1146/annurev-physiol-042022-015914.
Otvos F, Szucs E, Urai A, Koteles I, Szabo P, Varga Z
Sci Rep. 2023; 13(1):20305.
PMID: 37985681
PMC: 10660610.
DOI: 10.1038/s41598-023-46317-3.
Ma R, Kutchy N, Wang Z, Hu G
Mol Ther. 2023; 31(5):1332-1345.
PMID: 37012704
PMC: 10188913.
DOI: 10.1016/j.ymthe.2023.03.030.
Ramos-Gonzalez N, Groom S, Sutcliffe K, Bancroft S, Bailey C, Sessions R
Br J Pharmacol. 2023; 180(18):2341-2360.
PMID: 37005796
PMC: 10952505.
DOI: 10.1111/bph.16084.
Coutens B, Ingram S
Neuropharmacology. 2022; 226:109408.
PMID: 36584882
PMC: 9898207.
DOI: 10.1016/j.neuropharm.2022.109408.
Mu-opioid receptor and receptor tyrosine kinase crosstalk: Implications in mechanisms of opioid tolerance, reduced analgesia to neuropathic pain, dependence, and reward.
Gamble M, Williams B, Singh N, Posa L, Freyberg Z, Logan R
Front Syst Neurosci. 2022; 16:1059089.
PMID: 36532632
PMC: 9751598.
DOI: 10.3389/fnsys.2022.1059089.
Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking.
Maza N, Wang D, Kowalski C, Stoveken H, Dao M, Sial O
Nat Neurosci. 2022; 25(9):1179-1190.
PMID: 35982154
PMC: 10294603.
DOI: 10.1038/s41593-022-01135-0.
Cellular Tolerance Induced by Chronic Opioids in the Central Nervous System.
Adhikary S, Williams J
Front Syst Neurosci. 2022; 16:937126.
PMID: 35837149
PMC: 9273719.
DOI: 10.3389/fnsys.2022.937126.
Mechanism of opioid addiction and its intervention therapy: Focusing on the reward circuitry and mu-opioid receptor.
Zhang J, Song C, Dai J, Li L, Yang X, Chen Z
MedComm (2020). 2022; 3(3):e148.
PMID: 35774845
PMC: 9218544.
DOI: 10.1002/mco2.148.
Spoken and Unspoken Matters Regarding the Use of Opioids in Cancer.
Baker Rogers J, Higa G
J Pain Res. 2022; 15:909-924.
PMID: 35411188
PMC: 8994621.
DOI: 10.2147/JPR.S349107.
Potential therapeutic targets for the treatment of opioid abuse and pain.
Kiguchi N, Ko M
Adv Pharmacol. 2022; 93:335-371.
PMID: 35341570
PMC: 10948018.
DOI: 10.1016/bs.apha.2021.09.002.
Functional Selectivity of Dopamine D Receptor Signaling: Retrospect and Prospect.
Yang Y
Int J Mol Sci. 2021; 22(21).
PMID: 34769344
PMC: 8584964.
DOI: 10.3390/ijms222111914.
Pharmacological and genetic manipulations at the µ-opioid receptor reveal arrestin-3 engagement limits analgesic tolerance and does not exacerbate respiratory depression in mice.
He L, Gooding S, Lewis E, Felth L, Gaur A, Whistler J
Neuropsychopharmacology. 2021; 46(13):2241-2249.
PMID: 34257415
PMC: 8581001.
DOI: 10.1038/s41386-021-01054-x.
A photoswitchable GPCR-based opsin for presynaptic inhibition.
Copits B, Gowrishankar R, ONeill P, Li J, Girven K, Yoo J
Neuron. 2021; 109(11):1791-1809.e11.
PMID: 33979635
PMC: 8194251.
DOI: 10.1016/j.neuron.2021.04.026.
The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder.
Aquino J, Parida S, Sofuoglu M
Clin Drug Investig. 2021; 41(5):425-436.
PMID: 33818748
PMC: 8020374.
DOI: 10.1007/s40261-021-01032-7.
D,L-Methadone causes leukemic cell apoptosis via an OPRM1-triggered increase in IP3R-mediated ER Ca release and decrease in Ca efflux, elevating [Ca].
Lee J, Rosales J, Byun H, Lee K
Sci Rep. 2021; 11(1):1009.
PMID: 33441856
PMC: 7806773.
DOI: 10.1038/s41598-020-80520-w.
Antinociceptive, reinforcing, and pruritic effects of the G-protein signalling-biased mu opioid receptor agonist PZM21 in non-human primates.
Ding H, Kiguchi N, Perrey D, Nguyen T, Czoty P, Hsu F
Br J Anaesth. 2020; 125(4):596-604.
PMID: 32819621
PMC: 7565907.
DOI: 10.1016/j.bja.2020.06.057.
Voltage modulates the effect of μ-receptor activation in a ligand-dependent manner.
Ruland J, Kirchhofer S, Klindert S, Bailey C, Bunemann M
Br J Pharmacol. 2020; 177(15):3489-3504.
PMID: 32297669
PMC: 7348086.
DOI: 10.1111/bph.15070.
Agonist-selective recruitment of engineered protein probes and of GRK2 by opioid receptors in living cells.
Stoeber M, Jullie D, Li J, Chakraborty S, Majumdar S, Lambert N
Elife. 2020; 9.
PMID: 32096468
PMC: 7041944.
DOI: 10.7554/eLife.54208.
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain.
Gudin J, Fudin J
Pain Ther. 2020; 9(1):41-54.
PMID: 31994020
PMC: 7203271.
DOI: 10.1007/s40122-019-00143-6.